Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: A systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Du, Qingxia ^a   Jin, Jianmin ^a   Liu, Xiaofang ^a   Sun, Yongchang ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; MICROBIAL IDENTIFICATION; MORTALITY; OBSERVATIONAL STUDY; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; AGED; COHORT ANALYSIS; COMPLICATION; DIAGNOSTIC IMAGING; META ANALYSIS; MIDDLE AGED; X-RAY COMPUTED TOMOGRAPHY;

AGED; BRONCHIECTASIS; COHORT STUDIES; HUMANS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84961644303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150532     Document Type: Review

References (44)

1. Chapman KR, Mannino D M, Soriano J B, Vermeire PA, Buist AS, Thun M J, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27(1):188-207. PMID: 16387952
2. Pillai SG, Ge D, Zhu G, Kong X, ShiannaK V, Need AC, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. Plos Genet. 2009; 5(3):e1000421. doi: 10.1371/journal.pgen.1000421 PMID: 19300482
3. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002; 121(suppl5): 121S-126S.
4. Han M L K, Agusti A, Calverley PM, Celli B R, Criner G, Curtis J L, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182(5):598-604. doi: 10.1164/rccm.200912-1843CC PMID: 20522794
5. Han M L K. Clinical Correlations of Computed Tomography Imaging in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2013; 10(Suppl):S131-S137. doi: 10.1513/AnnalsATS.201303-046AW PMID: 24313763
6. Wedzicha JA, Hurst J R. Structural and functional co-conspirators in chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc. 2007; 4(8):602-605. PMID: 18073390
7. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2014)[EB/OL]. Available: http://www.goldcopd.org/Global-Initiative-for-Chronic-Obstructive-Lung-Disease.
8. Novosad SA, Barker A F. Chronic obstructive pulmonary disease and bronchiectasis. Curr Opin Pulm Med. 2013; 19(2):133-139. doi: 10.1097/MCP.0b013e32835d8312 PMID: 23287285
9. Arram EO, Elrakhawy M M. Bronchiectasis in COPD patients. Egyptian Journal of Chest Diseases and Tuberculosis. 2012; 61(4):307-312.
10. Martínez-García MA, de la Rosa D, Soler-Cataluña JJ, Donat-Sanz Y, Serra P C, Lerma M A, et al. Prognostic value of bronchiectasis in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 187:823-831. doi: 10.1164/rccm.201208-1518OC PMID: 23392438
11. Tulek B, Kivrak AS, Ozbek S, Kanat F, Suerdem M. Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J. 2013; 20(2):91-96. PMID: 23616965
12. Martinez-Garcia MA, Soler-Cataluna JJ, Donat Sanz Y, Serra PC, Lerma M A, Vicente J B, et al. Factors associated with bronchiectasis in patients with COPD. Chest. 2011; 140:1130-1137. doi: 10.1378/chest.10-1758 PMID: 21546440
13. Moher D, Liberati A, Tetzlaff J, Altman D G. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA Statement. Ann Intern Med. 2009; 151(4):264-9. PMID: 19622511
14. Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005; 165:891-897. PMID: 15851640
15. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbation of chronic obstructive pulmonary disease. N Engl J Med. 2002; 347:465-471. PMID: 12181400
16. Higgins J P T, Thompson S G, Deeks J J, Altman D G. Measuring inconsistency in meta-analyses. Bmj. 2003; 327(7414):557-560. PMID: 12958120
17. Duval S, Tweedie R. Trim and fill: a simple funnel plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-463. PMID: 10877304
18. Stewart JI, Maselli DJ, Anzueto A, CrinerG J, Han M K, Martínez F J. Clinical impact of CT radiological feature of bronchiectasis in the COPD Gene cohort. Am J Respir Crit Care Med. 2012; 185:A3656.
19. Sadigov AS, Akhundov S. Bronchiectasis associated with COPD: does it increase the mortality rate in patients with severe disease? Am J Respir Crit Care Med. 189;2014:A4257.
20. Jairam PM, van der Graaf Y, Lammers J-WJ, Willem PT M, de Jong PA, Laméris J. Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality. Thorax. 2015, 70(8):725-731. doi: 10.1136/thoraxjnl-2014-206160 PMID: 26024687
21. Patel IS, Vlahos I, Wilkinson TMA, Lloyd-Owen S J, Donaldson G C, Wilks M, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 170(4):400-407. PMID: 15130905
22. Roche N, Kouassi B, Rabbat A, Mounedji A, Lorut C, Huchon G. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration. 2006; 74(1):19-25. PMID: 16675894
23. Gatheral T, Kumar N, Sansom B, Lai D, Nair A, Vlahos I, et al. COPD-related bronchiectasis: independent impact on disease course and outcomes. COPD. 2014; 11(6):605-614. doi: 10.3109/15412555.2014.922174 PMID: 24983298
24. Gallego M, Pomares X, Espasa M, Castañer E, Solé M, Suárez D, et al. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. Bmc Pulmonary Medicine. 2014; 14(4):48-48.
25. García-Vidal C, Almagro P, Romaní V, Rodriguez-Carballeira M, Cuchi E, Canales L, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J. 2009; 34:1072-1078. doi: 10.1183/09031936.00003309 PMID: 19386694
26. Bafadhel M, Umar I, Gupta S, Raj J V, Vara D D, Entwisle J J, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011; 140:634-642. doi: 10.1378/chest.10-3007 PMID: 21454400
27. Katsura H, Ogata M, Kida K. Factors determining outcome in elderly patients with severe COPD on long-term domiciliary oxygen therapy. Arch Monaldi Mal Torace. 2001; 56(3):195-201.
28. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. doi: 10.1056/NEJMoa0909883 PMID: 20843247
29. Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha J A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000; 55:114-120. PMID: 10639527
30. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen S J, Donaldson G C, Wedzicha J A. Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations. Thorax. 2002; 57:759-764. PMID: 12200518
31. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin D P. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009; 374:1171-8. doi: 10.1016/S0140-6736(09)61298-8 PMID: 19716598
32. Davies G, Wells A U, Doffman S, Watanabe S, Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J. 2006; 28(5):974-979. PMID: 16899482
33. Valderrey AD, PozueloM J, Maciá M D, Oliver A, Rotger R. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. Diagn Microbiol Infect Dis. 2010; 68(1)20-27. doi: 10.1016/j.diagmicrobio.2010.04.008 PMID: 20727465
34. Martínez-Solano L, MaciaM D, Fajardo A, Oliver A, Martinez J L. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis. 2008; 47(12):1526-1533. doi: 10.1086/593186 PMID: 18990062
35. Davies G, Wells A U, Doffman S, Watanabe S, Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J. 2006; 28(5):974-979. PMID: 16899482
36. Murray MP, Turnbull K, MacQuarrie S, Hill AT. Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J. 2009; 33(2):312-318. doi: 10.1183/09031936.00122508 PMID: 18829674
37. White AJ, Gompertz S, Bayley D L, Hill S L, O'Brien C, Unsal I, et al. Resolution of bacterial inflammation is related to bacterial eradication following treatment of exacerbation of chronic bronchitis. Thorax. 2003; 58:680-685. PMID: 12885984
38. Wilson R, Anzueto A, Miravitlles M, Arvis P, Alder J, Haverstock D, et al. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J. 2012; 40(1):17-27. 5. doi: 10.1183/09031936.00090311 PMID: 22135277
39. Berger JS, Sanborn TA, Sherman W, Brown D L. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol. 2004; 94:649-51. PMID: 15342301
40. Adler KB, Hendley D D, Davis G S. Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways. Am. J. Pathol. 1986; 125(3):501. PMID: 3099581
41. Aziz ZA, Wells AU, Desai S R, Ellis SM, Walker A E, MacDonald S, et al. Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchyma disease. AJR Am J Roentgenol. 2005; 185(6):1509-1515. PMID: 16304005
42. Habesoglu MA, Tercan F, Ozkan U, Ellis S M, Walker A E, MacDonald S, et al. Effect of radiological extent and severity of bronchiectasis on pulmonary function. Multidiscip Respir Med. 2011; 6(5):284-290. doi: 10.1186/2049-6958-6-5-284 PMID: 22958727
43. Ni Y, Shi G, Yu Y, Hao J, Chen T, Song H. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015, 10:1465. doi: 10.2147/COPD.S83910 PMID: 26251586
44. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006 Nov; 11(6):731-40. PMID: 17052301